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Abstract 
Health during aging can be improved by genetic, dietary and pharmacological interventions. 
Many of these increase resistance to various stressors, including xenobiotics. Up-regulation 
of xenobiotic detoxification genes is a transcriptomic signature shared by long-lived 
nematodes, flies and mice, suggesting that protection of cells from toxicity of xenobiotics 
may contribute to longevity. Expression of genes involved in xenobiotic detoxification is 
controlled by evolutionarily conserved transcriptional regulators. Three closely related 
subgroups of nuclear hormone receptors (NHRs) have a major role, and these include DAF-12 
and NHR-8 in C. elegans, DHR96 in Drosophila and FXR, LXRs, PXR, CAR and VDR in mammals. 
In the invertebrates, these NHRs have been experimentally demonstrated to play a role in 
extension of lifespan by genetic and environmental interventions. NHRs represent critical 
hubs in that they regulate detoxification enzymes with broad substrate specificities, 
metabolizing both endo- and xenobiotics. They also modulate homeostasis of steroid 
hormones and other endogenous cholesterol derivatives and lipid metabolism, and these 
roles, as well as xenobiotic detoxification, may contribute to the effects of NHRs on lifespan 
and health during aging, an issue is being increasingly addressed in C. elegans and 
Drosophila. Disentangling the contribution of these processes to longevity will require more 
precise understanding of the molecular mechanisms by which each is affected, including 
identification of ligands and co-regulators of NHRs, patterns of tissue-specificity and 
mechanisms of interaction between tissues. The roles of vertebrate NHRs in determination 
of health during aging and lifespan have yet to be investigated. 
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Abbreviations 
20E, 20 hydroxy ecdysone; ABC transporter, ATP binding cassette transporters; AhR, aryl 
hydrocarbon receptor; CAR, constitutive androstane receptor; CYP, cytochrome P450 
enzyme; DA, dafachronic acid; DBD, DNA binding domain; DR, dietary restriction; EcR, 
ecdysone receptor; FOXO, forkhead Box O; FXR, farnesoid X receptor; GHRKO, growth 
hormone receptor knock out; GST, glutathione-S-transferase; IIS, insulin/insulin like growth 
factor signaling; LBD, ligand binding domain; LXR, liver X receptor; NHR, nuclear hormone 
receptor; PXR, pregnane X receptor; RXR, retinoid X receptor; SDR, short chain 
dehydrogenase; UGT, UDP-glucuronosyl-transferases; USP, Ultraspiracle; VDR, vitamin D 
receptor 
  
4 
 
 
 
Introduction 
The aging process has proved to be malleable to genetic, dietary and pharmacological 
interventions (Kenyon, 2010, Lamming et al., 2013, Fontana et al., 2010, Fontana and 
Partridge, 2015). Furthermore, at least some of its mechanisms are conserved during 
evolution, because similar interventions, such as dietary restriction (DR), have proved 
capable of improving health during aging in diverse model and non-model organisms 
including primates (Madeo et al., 2014). However, these interventions can also have 
undesirable side-effects, such as impaired fecundity, immunity and wound healing (Martin et 
al., 2008, Lamming et al., 2013). There is therefore much interest in understanding the exact 
mechanisms by which different interventions improve health during aging, and in the 
possibility of triaging the health benefits from the side-effects. 
One well established intervention to extend lifespan, in the nematode worm Caenorhabditis 
elegans, the fruit fly Drosophila melanogaster, mice and, possibly, humans, is reduction of 
insulin/insulin-like growth factor (Igf) signaling (IIS) (Fontana et al., 2010). The IIS pathway is 
conserved among metazoans, and it can modulate metabolism, development, growth, body 
size, fecundity and resistance to different stressors including oxidative and xenobiotic stress 
(Broughton and Partridge, 2009). It is therefore important to establish whether any, or all, of 
the many pleiotropic traits associated with reduced IIS are causal in increased lifespan and 
health during aging.  
Binding of insulin-like peptides to the insulin/Igf receptor induces a signaling cascade leading 
to the phosphorylation of forkhead Box O (FOXO) transcription factors by the protein kinase 
AKT and sequestration of FOXO in the cytoplasm. With reduced activity of the upstream 
pathway, FOXO translocates to the nucleus and regulates gene expression (van der Horst and 
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Burgering, 2007, Salih and Brunet, 2008, Partridge and Bruning, 2008). In C. elegans, all 
phenotypes associated with reduced IIS, including xenobiotic resistance, require the gene 
daf-16, which encodes the single worm FOXO and, from this evidence, all of the pleiotropic 
traits could hence be relevant to the extension of lifespan (Tissenbaum and Ruvkun, 1998, 
Honda and Honda, 1999, Riedel et al., 2013). In contrast, in Drosophila, dfoxo, the daf-16 
orthologue, is not required for the reduction in body size and fecundity, developmental delay 
or the increased oxidative stress resistance from reduced IIS. Only increased resistance to 
xenobiotics and extension of lifespan are identified FOXO-dependent effects of reduced IIS 
(Slack et al., 2011). It is thus possible that the increased xenobiotic resistance of insulin 
mutant flies is causal in their increased lifespan, while the other traits associated with 
reduced IIS are irrelevant. 
In accordance with their increased xenobiotic resistance, the RNA transcriptomic signature of 
long-lived IIS mutant worms, flies and mice is enriched for xenobiotic detoxification genes 
(McElwee et al., 2007). Furthermore, various genetic, pharmacological and dietary 
interventions that promote longevity in mice also increase expression of detoxification 
genes. Little mice, harboring a growth hormone releasing hormone receptor knockout, and 
Ames dwarf, lacking pituitary cells producing growth hormone, prolactin and thyroid 
stimulating hormone, have a transcriptomic signature of elevated xenobiotic detoxification 
genes (Amador-Noguez et al., 2004) and Little mice are resistant to hepatotoxins (Amador-
Noguez et al., 2007). Other murine models of delayed aging also show increased expression 
of xenobiotic metabolizing enzymes (Miller et al., 2014, Steinbaugh et al., 2012). These 
include Snell dwarf mice, which carry mutations hindering normal pituitary development, 
growth hormone receptor knock out (GHRKO) mice, and mice subjected to DR, reduced 
access to the mother during the breastfeeding period (‘crowded litter’), or treated with 
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rapamycin. Furthermore, DR mice showed increased resistance to acetaminophen and other 
hepatotoxins, such as thioacetamide and bleomycin (Aidoo et al., 1999, Apte et al., 2003, 
Harper et al., 2006). Methionine-restricted mice are also less susceptible to acetaminophen 
(Miller et al., 2005). Taken together, these findings point to increased metabolism of endo- 
and xenobiotics as a potential downstream mechanism for mediating the effects of multiple 
interventions promoting health during aging.  
Detoxification of endo- and xenobiotics is divided into three phases. In phase I, cytochrome 
P450 enzymes (CYPs) and short chain dehydrogenases (SDRs) bioactivate the lipophilic 
components, providing conjugation sites for consecutive reactions. Different classes of phase 
II enzymes then conjugate bulky hydrophilic groups to the molecules to increase their 
solubility in body fluids and facilitate their excretion. Phase II enzymes include glutathione-S-
transferases (GSTs), UDP-glucuronosyl-transferases (UGTs), sulfotransferases, 
carboxylesterases and others. The third phase is accomplished by the ABC (ATP binding 
cassette) transporters, which excrete the detoxified molecules (Omiecinski et al., 2011). 
Notably, all steps of detoxification are highly energy demanding (Gems and McElwee, 2005).  
The main transcriptional regulators of detoxifying enzymes and transporters are conserved 
among metazoans and include the aryl hydrocarbon receptor (AhR), the zinc-finger 
transcription factor Nrf-2 and members of two closely related subgroups of nuclear hormone 
receptors (NHRs) (Lindblom and Dodd, 2006, Brown et al., 2005, Sykiotis and Bohmann, 
2008, Itoh et al., 2015, Köhle and Bock, 2009, Wang et al., 2013). NHRs are classified into 
groups NR1-NR6, and into subgroups according to their highly conserved domain structure 
(Nuclear Receptors Comittee, 1999). The NHRs relevant for xenobiotic metabolism in 
invertebrate models belong to the NR1J group and include DAF-12, NHR-8 and NHR-48 in C. 
elegans and DHR96 in Drosophila. While NHR-8 and DHR96 are demonstrated to regulate 
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xenobiotic detoxification, DAF-12 and NHR-48 have not yet been studied regarding this 
possible function (King-Jones et al., 2006, Lindblom et al., 2001). The NR1J group is closely 
related to the NR1I group, with mammalian pregnane X receptor (PXR), constitutive 
androstane receptor (CAR) and vitamin D receptor (VDR), and to the NR1H group with 
farnesoid X receptor (FXR) and liver X receptors (LXRs) (Fig. 1). PXR and CAR have a well-
established role in regulating xenobiotic metabolism, while VDR, FXR and LXRs, like many 
other mammalian NHRs, induce expression of xenobiotic detoxification genes and cross-talk 
with xenobiotic metabolism (Haussler et al., 2013, Wang et al., 2013, Xu et al., 2005).  
Interestingly, in worms and flies, genes that regulate xenobiotic metabolism are also 
implicated in healthy aging. For instance, over-expression of skn-1, the Nrf2 orthologue, in C. 
elegans, extends lifespan and its activity is required for the response of lifespan to DR (Tullet 
et al., 2008, Bishop and Guarente, 2007). Furthermore, over-expression of the Nrf2 
orthologue cnc in Drosophila extends lifespan (Sykiotis and Bohmann, 2008), while nhr-8 is 
required for DR to extend lifespan in C. elegans (Chamoli et al., 2014, Thondamal et al., 
2014). Although daf-12 has not been shown to be involved in xenobiotic metabolism, it is 
well established to promote healthy aging: daf-12 is required for increased longevity induced 
by loss of the germline (Hsin and Kenyon, 1999, Wollam et al., 2012). Furthermore a gain of 
function mutant of daf-12 is long-lived (Fisher and Lithgow, 2006). On the other hand, 
although dhr96 is involved in the response to xenobiotics, it has not yet been studied 
regarding its involvement in healthy aging (King-Jones et al., 2006).  
In addition to their possible roles in detoxification of xenobiotics, NHRs of the NR1H, NR1I 
and NR1J groups control homeostasis of sterol metabolites and fat metabolism. DAF-12 and 
NHR-8 in worms and DHR96 in flies regulate cholesterol and triacylgylceride metabolism and 
furthermore all three are involved in biosynthesis and/or degradation of steroid hormones 
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that govern developmental decisions and are involved in healthy aging (Horner et al., 2009, 
Bujold et al., 2009, Magner et al., 2013, Antebi, 2013b, Wang et al., 2015, King-Jones et al., 
2006, Guittard et al., 2011). Mammalian LXRs have a well-established role in controlling 
cholesterol homeostasis, while FXR acts as the main bile acid sensor and is also involved in 
triacylglyceride homeostasis (Kalaany and Mangelsdorf, 2006). Next to xenobiotics, 
mammalian PXR and CAR bind a wide range of endogenous ligands including bile acids, 
bilirubin, and steroid hormones, and are involved in control of bile acid homeostasis, lipid 
metabolism and gluconeogenesis, as well as regulation of steroid and thyroid hormone levels 
(Yang and Wang, 2014, Wang et al., 2013, Moreau et al., 2008, di Masi et al., 2009). VDR is 
activated by bile acids and, furthermore, polyunsaturated fatty acids are ligands for VDR, 
albeit with low affinities (Makishima et al., 2002, Adachi et al., 2005, Haussler et al., 2013).  
The increased expression of genes involved in xenobiotic metabolism, and the xenobiotic 
resistance seen in animal models of healthy aging, together with the dual involvement of 
transcription factors in regulating xenobiotic metabolism and healthy lifespan, all suggest 
that there may be a causal connection between the two traits. Since NHRs involved in 
detoxification of xenobiotics also regulate endogenous metabolites and hormones, this role 
could also contribute to healthy aging. To determine whether these associations are indeed 
causal will require unravelling the exact mechanisms by which NHRs modulate the different 
traits. In this review, we consider this issue, with particular emphasis on the invertebrate 
NHRs of the NR1J group, DAF-12, NHR-8 and DHR96, with discussion of their mammalian 
orthologues where relevant. Although NHR-48 also belongs to the NR1J group its functions 
are largely unknown, and it will hence not be further discussed. We focus on the role of 
these NHRs in worms and flies because their role in lifespan and health during aging has 
been much more extensively investigated than has that of vertebrate NHRs.  We first provide 
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an overview over structure and function of NHRs. We then discuss whether increased 
xenobiotic metabolism and/or control of sterol and triacylglyceride metabolism by NHRs 
contributes to health during aging.  
 
Nuclear hormone receptors 
Nuclear hormone receptors comprise a large superfamily of proteins that are usually ligand-
dependent transcription factors. They serve a wide variety of functions, including regulation 
of development, mitochondria, immunity, sex determination and reproduction, as well as 
lipid metabolism and detoxification of endo- and xenobiotics. They are evolutionarily 
conserved in metazoans, with 18 members in Drosophila, 48 in human, 49 in mice, and 284 
in nematodes (Evans and Mangelsdorf, 2014, Fahrbach et al., 2012). Because both their DNA-
binding domain (DBD) and ligand-binding domain (LBD) show high evolutionary 
conservation, NHRs are grouped into subfamilies and subgroups based on the phylogenetic 
comparison of these domains (Nuclear Receptors Comittee, 1999).  
The ligands of NHRs are always lipophilic but are highly variable in size and structure (Laudet 
et al., 2005). Examples include glucocorticoids, steroid hormones, fatty acids, phospholipids, 
heme, bile acids, vitamin D and xenobiotics (Huang et al., 2010). Some NHRs are orphan 
receptors, meaning either that they do not have ligands or that these have not yet been 
identified. Furthermore, some NHRs constitutively bind their ligands in the manner of a co-
factor, for instance HNF-4 and fatty acids (Evans and Mangelsdorf, 2014). Ligand specificity 
and affinity varies greatly between the family members. The human PXR, for example, binds 
various ligands with low affinities (in the micromolar range) whereas steroid receptors are 
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highly specific for their cognate ligands and bind these with high affinity (0.1-1 nM) (Reschly 
and Krasowski, 2006, Huang et al., 2010). 
As illustrated in Fig. 2A, NHRs have a modular structure. The N-terminal region (A/B domain) 
is variable and serves in ligand-independent transactivation. The central DBD is highly 
conserved and has two zinc finger motifs providing DNA binding. The highly variable hinge 
region connects the DBD and LBD and also contains the C-terminal extensions, which bind to 
the DNA minor groove just C-terminal of the DBD (Huang et al., 2010, Laudet et al., 2005). 
The C-terminal LBD is evolutionarily conserved, but not as highly as the DBD (Bertrand et al., 
2004), and contains the ligand-binding pocket. Its structure allows interaction with 
dimerization partners as well as co-regulators and other transcription factors.  
The ligand-binding pocket is buried deeply in the molecule, in accordance with the lipophilic 
nature of the ligands. Upon ligand binding, helix 12 of the LBD is subjected to a 
conformational change, resulting in recruitment of co-regulators. Classically, in the absence 
of the ligand, NHRs are thought to bind to co-repressors, which are exchanged for co-
activators upon ligand-binding (Fig. 2C) (Huang et al., 2010). However, regulation of the 
transactivating activity of NHRs is more complex. NHRs can also act only as activators or only 
as repressors (Fig. 2C). Furthermore, unliganded NHRs can constitutively activate 
transcription, with ligands acting as inverse agonists and repressing transcription, as is the 
case for mammalian CAR (Fig. 2C) (Evans and Mangelsdorf, 2014). Detailed models of 
transcriptional repression by NHRs in interaction with ligands, co-regulators and other NHRs 
are reviewed elsewhere (Santos et al., 2011). 
Activity of NHRs is not solely regulated by presence or absence of ligands. Transactivating 
activity can be regulated by phosphorylation, as in the estrogen receptor (Kato et al., 1995, 
White et al., 1997). Furthermore, some NHRs reside in the cytoplasm bound to chaperones 
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in the absence of their ligands. For instance the glucocorticoid and androgen receptors are 
associated with a protein complex including HSP70 and HSP90, and ligand binding induces 
release from the complex and translocation into the nucleus (Kawata, 2001).  
The spectrum of genes regulated by a given NHR, and whether it activates or represses 
particular genes, can differ between tissue and cell types. This specificity probably depends 
upon the local availability of co-activators and co-repressors, since binding of these two 
types of co-regulators to the surface of the NHR is mutually exclusive (Huang et al., 2010).  
NHRs can bind to the DNA as monomers, homodimers or heterodimers (Fig. 2B). This is 
reflected in the arrangement of their hexameric DNA binding motifs, with monomers binding 
to single hexamers, homodimers binding to inverted repeats and heterodimers binding to 
direct repeats of the hexameric motifs (Evans and Mangelsdorf, 2014). Many NHRs, including 
mammalian VDR, FXR, LXRs, retinoic acid receptors (RARs), PXR and CAR, form heterodimers 
with retinoic X receptor (RXR). Of note, RXR is the only heterodimerization partner for all 
other NHRs. (Evans and Mangelsdorf, 2014). RXR heterodimers can be activated by both the 
RXR ligand retinoic acid and the cognate ligand of the heterodimerization partner 
(‘permissive heterodimer’), or only by the ligand of the partner (‘non-permissive 
heterodimer’) (Evans and Mangelsdorf, 2014). Permissive partners include peroxisome 
proliferator-activated receptors (PPARs), LXRs, FXR, PXR and CAR, while thyroid receptors 
(TRs), VDR and RARs are non-permissive partners. In invertebrates heterodimerization of 
NHRs has not been described at this level of detail. However, the Drosophila ecdysone 
receptor (EcR) heterodimerizes with USP, the RXR homolog in flies (Yao et al., 1993, Horner et 
al., 1995). Of note, C. elegans does not harbor a homolog of RXR but heterodimerization 
between different NHRs has been observed in worms (Li et al., 2004). 
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NHRs commonly have multiple isoforms that can serve different functions. Differences in the 
N-terminal region result in different transactivating activities, and isoforms can lack the DBD 
and hence sequester ligands without regulating target genes. Some isoforms act as dominant 
negative receptors, by binding the DNA without regulating transcription (Laudet et al., 2005). 
In addition, NHR signaling is autoregulated at two levels. NHRs regulate their own 
expression, and promotors of NHRs often hold their own binding motif (Laudet et al., 2005). 
NHRs can also regulate the production of their ligands by transcriptional control of enzymes 
necessary for their biosynthesis (Evans and Mangelsdorf, 2014). 
 
Xenobiotic resistance: a cause for NHR dependent longevity? 
The role of NHRs in longevity and healthy aging has been addressed mainly in C. elegans and 
Drosophila. We therefore focus on these organisms to consider the possible roles of  
xenobiotic, lipid and cholesterol metabolism in mediating the effects of DAF-12, NHR-8 and 
potentially DHR96 activity on longevity. 
 
DAF-12, NHR-8 and DHR96 in xenobiotic resistance and longevity 
The ligands of DAF-12 are dafachronic acids (DAs), which are synthesized by the CYP DAF-9 
and other enzymes from a cholesterol precursor (Mahanti et al., 2014, Gerisch and Antebi, 
2004, Gerisch et al., 2001, Rottiers et al., 2006, Schaedel et al., 2012, Wollam et al., 2012). 
While unliganded DAF-12 is associated with the co-repressor DIN-1 and represses target 
gene expression (Ludewig et al., 2004), binding of DAs is thought to induce expression of 
target genes (Antebi, 2013c). DAF-12 signaling interacts with IIS, signals from the germline 
and environmental conditions to modulate healthy aging and can have opposed effects on 
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longevity. Reduced DA/DAF-12 signaling can be achieved by mutating different components 
of the pathway, including the enzymes for DA biosynthesis and DAF-12 itself. The effect of 
daf-9 mutation on lifespan is temperature-dependent (Tab. 1). All 4 daf-9 alleles tested 
increase lifespan at 15 °C (Jia et al., 2002, Gerisch et al., 2007, Gerisch et al., 2001). However, 
this effect is lost or even reversed at higher temperatures up to 25 °C (Jia et al., 2002, Gerisch 
et al., 2007, Gerisch et al., 2001, Dumas et al., 2013, Thondamal et al., 2014). Extension of 
lifespan in daf-9 mutants at 15 °C is completely dependent upon daf-12, indicating that 
unliganded DAF-12 is required for longevity at this temperature (Gerisch et al., 2001, Jia et 
al., 2002). Accordingly, the null allele daf-12(rh61rh411) alone either reduces (20 °C) or does 
not change (25 °C) lifespan (Fisher and Lithgow, 2006, Dumas et al., 2013) but the LBD 
deficient mutant daf-12(rh273) shows extended lifespan at 20 °C (Fisher and Lithgow, 2006). 
Furthermore, the co-repressor DIN-1, which is associated with DAF-12 in the absence of 
ligands, is required for longevity seen in daf-9 mutants (Ludewig et al., 2004). These findings 
indicate that, in otherwise untreated animals, unliganded rather than liganded DAF-12 serves 
to extend lifespan, and DAF-12 together with DIN-1 represses genes whose functions 
counteract longevity.  
Whether DA signaling affects xenobiotic resistance has not yet been assessed, but reduced 
DA signaling increases resistance to other stressors. Both long-lived daf-9 and LBD deficient 
daf-12(rh273) mutants exhibit resistance to thermal and oxidative stress (Gerisch et al., 
2007, Fisher and Lithgow, 2006). In daf-9 mutants, resistance is abrogated when daf-9 
expression is restored or when they are treated with a DAF-12 agonist (Gerisch et al., 2007). 
Furthermore, increased resistance of daf-9 mutants depends upon daf-12 and its co-
repressor din-1, indicating that unliganded DAF-12 acts to increase stress resistance (Gerisch 
et al., 2007). It has been proposed that resistance against a broad range of stressors is a 
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longevity-assurance mechanism (Gems and McElwee, 2005, Shore and Ruvkun, 2013), which 
could suggest that long-lived mutants that are resistant to thermal and oxidative stress 
would also be more resistant to xenobiotic stress. The hypothesis further implies that 
interventions that abrogate increased stress resistance should also abrogate longevity of 
these mutants. However, the increased stress tolerance of daf-9 mutants is partially 
dependent on daf-16 while their longevity is not abrogated by daf-16 mutation (Gerisch et 
al., 2007, Gerisch et al., 2001, Jia et al., 2002), indicating that increased resistance against 
these two stressors can be at least partially uncoupled from longevity. 
Further evidence arguing against xenobiotic detoxification as a cause for longevity in mutants 
with reduced DA signaling comes from comparison of genes differentially regulated between 
long-lived daf12(rh273) and short-lived daf-12(rh61rh411) mutants. Genes involved in phase 
I and II detoxification, including CYPs, GSTs and glucuronosyltransferases, are down-regulated 
in long-lived daf-12(rh273) mutants (Fisher and Lithgow, 2006) while, in contrast, xenobiotic 
detoxification genes are up-regulated in long-lived worms, flies and mice (McElwee et al., 
2007). Xenobiotic resistance is thus unlikely to be causal for healthy aging of mutants with 
reduced DA/DAF-12 signaling. However, due to the correlative nature of these findings this 
conclusion remains speculative. Future work should assess the xenobiotic resistance of long-
lived DA/DAF-12 mutants and any possible role in determination of lifespan.  
NHR-8 is required for normal levels of xenobiotic resistance, because both nhr-8(ok186) 
mutants and worms subjected to nhr-8 RNAi treatment are sensitive to xenobiotics 
(Lindblom et al., 2001). However, nhr-8(ok186) mutants do not exhibit reduced resistance 
against phenazine indicating that NHR-8 confers resistance against a specific subset of 
xenobiotics (Lindblom et al., 2001). Furthermore, NHR-8 appears to have redundant 
functions with other transcriptional regulators in regulating xenobiotic detoxification genes, 
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because nhr-8 RNAi treatment does not abrogate expression of selected phase I and II 
enzymes (Chamoli et al., 2014, Jones et al., 2013). Interestingly, NHR-8 is necessary for the 
response of lifespan to DR in C. elegans (Chamoli et al., 2014, Thondamal et al., 2014). It 
remains to be tested whether xenobiotic resistance is increased by DR and contributes to 
longevity of DR worms. The finding that skn-1, the Nrf-2 ortholog in C. elegans, is also 
necessary for DR in C. elegans supports this idea (Bishop and Guarente, 2007).  
Analogous to nhr-8 mutants, dhr961 loss of function mutants are sensitive to xenobiotics, 
including phenobarbital, DDT and permethrin (King-Jones et al., 2006, Beaver et al., 2010). 
Over-expression of dhr96 in L3 larvae induces expression of xenobiotic detoxification genes 
independently of treatment with xenobiotics and in addition, DHR96 is required for induction 
of xenobiotic detoxification genes by phenobarbital treatment, including Turandot genes, 
acyl-CoA synthetases, CYPs, GstD7 and juvenile hormone binding proteins (JHBPs), which 
serve as lipid carriers in the hemolymph (King-Jones et al., 2006). However, the responses to 
phenobarbital of some xenobiotic detoxification genes, including Cyp6a8 and GstD2, are 
unaffected by loss of dhr96 (King-Jones et al., 2006). These findings suggest that DHR96 is 
not solely responsible for the gene expression changes in response to phenobarbital and 
other transcriptional regulators, for instance the Nrf2 ortholog CNC or the aryl hydrocarbon 
receptor AhR, could also be involved in xenobiotic metabolism because their mammalian 
counterparts regulate xenobiotic detoxification genes (Köhle and Bock, 2009, Okawa et al., 
2006).  
 
Increased xenobiotic resistance of long-lived IIS mutants – mediated by NHRs? 
In flies, long-lived IIS mutants are resistant to xenobiotics and furthermore, xenobiotic 
detoxification genes are up-regulated in long-lived mutants with reduced IIS in worms, flies 
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and mice (McElwee et al., 2007, Gronke et al., 2010, Slack et al., 2011). DHR96 is likely to act 
down-stream of reduced IIS in flies because it is a direct target gene of FOXO and xenobiotic 
resistance is a FOXO-dependent trait of IIS mutants (Alic et al., 2011, Slack et al., 2011, King-
Jones et al., 2006). These findings suggest that DHR96 might contribute to increased 
xenobiotic resistance and longevity of IIS mutants.  
In C. elegans, long-lived daf-2 mutants share transcriptomic signatures of increased 
detoxification genes with fly IIS mutants (McElwee et al., 2007, McElwee et al., 2004). 
Whether long-lived daf-2 mutants are actually resistant to xenobiotics has not been assessed 
but further evidence suggests that xenobiotic detoxification and longevity are coupled in 
worms (Shore et al., 2012): many mutations that disrupt cytoprotective mechanisms 
including resistance to different xenobiotics also abrogate longevity of daf-2 mutants (Shore 
et al., 2012). Necessity of nhr-8 or daf-12 for daf-2-dependent longevity would provide an 
indirect hint for the putative involvement of these NHRs in the regulation of xenobiotic 
detoxification down-stream of IIS. nhr-8 is not necessary for longevity from reduced IIS 
indicating that it does not contribute to xenobiotic resistance and longevity from reduced IIS 
(Thondamal et al., 2014).  In contrast, DA/DAF-12 signaling interacts with IIS in a context- and 
temperature-dependent manner to modulate lifespan (Tab. 1). Longevity induced by both 
weak daf-2(e1368) and strong daf-2(e1370) alleles is abrogated by daf-9 mutation at 15 °C, 
but at higher temperatures daf-9 mutation shortens lifespan of daf-2(e1368) and further 
extends lifespan of daf-2(e1370) (Gerisch et al., 2001, Dumas et al., 2013). Correspondingly, 
∆4-DA supplementation further extends daf-2(e1368) lifespan but has no effect on daf-
2(e1370) longevity (Gerisch et al., 2007). Furthermore, different daf-12 mutations affecting 
different DAF-12 isoforms influence longevity of daf-2 mutants in opposing directions (Gems 
et al., 1998, Larsen et al., 1995, McCulloch and Gems, 2007, Dumas et al., 2013). These 
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complex phenotypes suggest intense cross-talk between DA/DAF-12 and IIS pathways. 
However, since combination of different daf-2 mutations with mutants impaired in DA/DAF-
12 signaling have different effects on longevity, assessing their xenobiotic resistance in 
parallel to their lifespan phenotypes could prove useful to test whether xenobiotic resistance 
and longevity are coupled in these long-lived mutants.  
 
Xenobiotic resistance as a cause for longevity – open questions 
The experimental evidence is not yet sufficient to determine whether xenobiotic resistance 
per se improves health during aging. In C. elegans, a causal connection between xenobiotic 
detoxification and longevity could be implied by the common role of skn-1, reduced activity 
of which interferes with both xenobiotic resistance and longevity (Shore et al., 2012, Tullet et 
al., 2008). However, it remains to be assessed whether xenobiotic resistance is increased by 
interventions that extend lifespan in C. elegans. Many DR-like interventions increase 
xenobiotic resistance in rodents. Therefore it would be interesting to investigate whether DR 
worms are resistant to xenobiotics as well and, if so, to assess the role of skn-1 and nhr-8 as 
candidates for mediating the effect, since both regulate expression of xenobiotic 
detoxification genes and are necessary for longevity of DR worms (Bishop and Guarente, 
2007, Chamoli et al., 2014, Thondamal et al., 2014, Lindblom et al., 2001). 
In flies and rodents, a correlation between increased xenobiotic resistance and longevity has 
been observed. However, it is unclear whether increased resistance is causal for healthy 
aging. In flies, longevity and increased xenobiotic resistance are phenotypes resulting from 
reduced IIS in a FOXO-dependent manner (Slack et al., 2011). Because DHR96 is a target gene 
of FOXO (Alic et al., 2011), DHR96 is a promising candidate to mediate the beneficial effect of 
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reduced IIS on xenobiotic resistance and longevity. To confirm this hypothesis it needs to be 
tested whether interventions that increase the activity of DHR96 extend lifespan. 
Furthermore, if IIS mutants are long-lived because of their increased xenobiotic resistance, 
then longevity of these mutants should be abrogated in a DHR96 null background. However, 
since DHR96 is probably not the only transcriptional regulator of xenobiotic metabolism in 
flies, other relevant regulators of xenobiotic detoxification genes, namely CNC and AhR, 
should also be examined for a possible role downstream of interventions that improve health 
during aging. 
In rodents, the causal connection between increased xenobiotic resistance and longevity also 
requires testing. However, this will not be a trivial undertaking, because several many 
transcriptional regulators, including PXR, CAR, VDR, FXR, Nrf2, and AhR, regulate 
detoxification enzymes, and it is likely that they can compensate for each other (Wang et al., 
2013, Haussler et al., 2013, Itoh et al., 2015, Köhle and Bock, 2009). One possibility would be 
to test whether longevity of Little mice is abrogated in a FXR null background. These mice 
have elevated levels of xenobiotic detoxification genes, which is lost in an FXR null 
background, while xenobiotic gene expression is unaffected in Little mice in a PXR/CAR 
double mutant background (Amador-Noguez et al., 2007). If longevity of Little mice is also 
abrogated in a FXR null background then this would suggest that increased xenobiotic 
resistance could be causal for longevity. However, FXR has a well-established role in 
regulation of bile acid levels by regulating detoxification enzymes, and this function of FXR 
could also contribute to longevity of Little mice. 
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Xenobiotic resistance of long-lived models – a bystander effect? 
Deregulated expression of xenobiotic detoxification genes in long-lived mutants could also 
point to changes in levels of steroid hormones or other lipophilic metabolites. In mammals, 
homeostasis of lipophilic signaling molecules and metabolites such as steroid hormones, bile 
acids or bilirubin, is controlled by the enzyme classes that act in xenobiotic detoxification 
(Gibson and Skett, 1986, di Masi et al., 2009). This implies that, for example, steroid hormone 
homeostasis and xenobiotic detoxification are intimately connected. It remains to be studied 
whether these processes are interrelated also in the long-lived invertebrate models, 
although it seems very likely given the structural similarities of, for example, DAs with bile 
acids (Mahanti et al., 2014). Therefore, the unexpected down-regulation of detoxification 
genes in long-lived LBD deficient daf-12(rh273) mutants in C. elegans might reflect changes 
in DA homeostasis. Bile acids are degraded by CYPs (di Masi et al., 2009) and the same is 
likely to apply to degradation of DAs. Furthermore, the production of DAF-12 ligands is 
achieved by CYPs and short chain dehydrogenases and other enzymes that are yet to be 
identified (Mahanti et al., 2014). Given the broad substrate specificities of CYPs (Gibson and 
Skett, 1986), some of the enzymes that have, as of yet, been described only as detoxification 
enzymes might also be involved in DA biosynthesis. In further support of this idea, both DAF-
12 and DHR96 regulate CYPs involved in steroid hormone homeostasis. DAF-12 regulates 
expression of DAF-9, required for biosynthesis of DAs (Gerisch and Antebi, 2004, Mak and 
Ruvkun, 2004) and DHR96 regulates CYP18a1, which is involved in catabolism of 20 hydroxy 
ecdysone (20E), a major steroid hormone in Drosophila (King-Jones et al., 2006, Guittard et 
al., 2011). In summary, differential expression of xenobiotic detoxification genes in long-lived 
animal models suggests that, as well as the potential to reduce toxic endo- and xenobiotic 
molecules, levels of steroid hormones and their metabolites are changed. This implies that 
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physiological functions that are under control of these hormones may be causal for healthy 
aging of these animals. Accordingly, steroid hormones like DAs in worms and 20 E in flies 
modulate lifespan (Gerisch et al., 2007, Simon et al., 2003, Tricoire et al., 2009). The roles of 
steroid signaling in healthy aging are reviewed in detail elsewhere (Toivonen and Partridge, 
2009, Galikova et al., 2011). Comprehensive analyses of the substrate specificities of CYPs, 
SDRs and other enzymes involved in detoxification and steroid hormone biosynthesis could 
prove very useful to disentangle cause from effect.  
Apart from endo- and xenobiotic metabolism members of the NR1J group control lipid 
metabolism and reproduction. These functions, which we shall consider in the next section, 
are likely to mediate healthy aging and, furthermore, their effects on longevity might be 
interrelated.  
 
NHRs, lipid metabolism, germline and aging 
Deregulated fat and cholesterol homeostasis has a major impact on health during aging 
resulting in type II diabetes and cardiovascular disease (Barzilai et al., 2012). In addition, lipid 
metabolism and reproduction mutually influence each other and both affect the aging 
process (Hansen et al., 2013). However, the connection of the three processes is as of yet 
unresolved. Interestingly, DAF-12, NHR-8 and DHR96 all either cross-talk with signals from 
the germline to modulate healthy aging or control reproduction in response to nutrient 
availability.  
DA/DAF-12 signaling is required for longevity of worms lacking a germline, a phenomenon 
referred to as germline longevity or gonadal longevity (Tab. 1) (Hsin and Kenyon, 1999, 
Gerisch et al., 2001, Yamawaki et al., 2010). The primordial germline of C. elegans comprises 
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four stem cells, with two somatic and two germline stem cells. When the germline stem cells 
are ablated by laser microsurgery, worms are sterile and live 60 % longer than intact animals 
(Hsin and Kenyon, 1999). However, if the gonadal stem cells are ablated as well, animals are 
not long-lived (Hsin and Kenyon, 1999, Arantes-Oliveira et al., 2002). Importantly, modulation 
of adult lifespan by the germline is conserved in flies and mice (Flatt et al., 2008, Cargill et al., 
2003, Mason et al., 2009). Much effort has been made to understand how signals from the 
germline affect aging reviewed in detail by (Antebi, 2013a). One candidate mechanism by 
which germline signals may modulate healthy aging is through regulation of fat metabolism. 
This idea is supported by the finding that the triacylglycerol lipases lips-17 and lipl-4 and the 
fatty acyl-CoA reductase fard-1 are necessary for germline longevity, and that overexpression 
of lipl-4 is sufficient to extend lifespan in C. elegans (Wang et al., 2008, McCormick et al., 
2012). Interestingly, fard-1 is a target gene of DAF-12, suggesting that control of lipid 
metabolism is a mechanism by which DAF-12 modulates healthy aging. In further support of 
this idea, DA/DAF-12 signaling induces mobilization of fat stores and fatty acid oxidation 
(Wang et al., 2015).  
NHR-8 also regulates lipid metabolism. RNAi against nhr-8 increases fat content and, 
furthermore, NHR-8 controls cholesterol homeostasis in worms that are cholesterol 
auxotroph (Ashrafi et al., 2003, Magner et al., 2013). By regulation of apolipoproteins, NHR-8 
regulates distribution of cholesterol throughout the body and, specifically, its transport into 
eggs (Magner et al., 2013). Evidently, this function has implications for the control of 
reproduction in the adult worm, because NHR-8 is necessary for decreased proliferation of 
germline stem cells under nutrient deprivation (Thondamal et al., 2014). This opens up the 
possibility that NHR-8 mediates the beneficial effects of DR by the reduction of germ cell 
signals that shorten lifespan. In addition, by controlling cholesterol uptake, NHR-8 also 
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regulates availability of precursors for biosynthesis of steroid hormones such as DAs, 
reflected in the developmental phenotypes of nhr-8 mutants, which resemble those of DA-
deficient animals (Magner et al., 2013). This suggests that NHR-8 signaling might also 
interfere with effects of DA/DAF-12 signaling on health during aging. 
DHR96 performs very similar functions in flies to those of NHR-8 in worms. Flies are also 
cholesterol auxotroph, and DHR96 adjusts cholesterol metabolism to varying levels of 
cholesterol in the food (Horner et al., 2009, Bujold et al., 2009). As implied by the parallel 
regulation of DA levels by NHR-8 in worms, DHR96 may also control availability of precursors 
for steroid hormones that modulate healthy aging. Furthermore, DHR96 also regulates 
reproduction in response to nutrient availability. In response to starvation, germline stem 
cells, as well as follicular stem cells, which give rise to the somatic gonad in flies, cease to 
proliferate until nutrients are available again (LaFever and Drummond-Barbosa, 2005). 
DHR96 is necessary for proliferation of follicular stem cells when flies are re-fed after a 
starvation period (Hartman et al., 2013). The response to re-feeding is further dependent on 
the cholesterol content of the food, indicating that the cholesterol-sensing function of 
DHR96 is responsible for the control of the response. Although it has not yet been addressed 
whether DHR96 also controls germline stem cell proliferation, by inference from the role of 
NHR-8 in adjusting germline stem cell proliferation to cholesterol availability, DHR96 could 
play a role in germline longevity in flies. 
Finally, DHR96 regulates many genes involved in fat metabolism including magro, a gastric 
triacylglycerol lipase and cholesterol esterase (Sieber and Thummel, 2009). In addition to its 
function in cholesterol homeostasis, magro facilitates uptake of lipids from the food by 
liberating fatty acids from triacylglycerides (Horner et al., 2009, Bujold et al., 2009, Sieber 
and Thummel, 2009, Sieber and Thummel, 2012). Since magro is an ortholog of lipl-4 in C. 
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elegans, it would be interesting to investigate whether over-expression of magro also 
improves health during aging in flies. 
 
Molecular functions of NR1J group members 
While invertebrate animal models have proven very useful to gain insights into the biological 
mechanisms of the aging process and have helped to identify members of the NR1J group as 
important mediators of interventions that promote health during aging, we lack 
comprehensive knowledge of their molecular functions. To better understand the proximal 
mechanisms by which these NHRs might confer longevity, it will be necessary to decipher 
how they function molecularly to control the correlated phenotypes, i.e. xenobiotic 
resistance, steroid/lipid homeostasis and lifespan.  
In C. elegans DAF-12 has three isoforms, with DAF-12A1 and DAF-12A3 being very similar and 
DAF-12B lacking the DBD (Antebi et al., 2000). Interestingly, the daf-12(m20) mutation, that 
affects only the DAF-12A isoforms, has different effects on longevity from those of the daf-
12(rh61rh411) null mutation, which deletes all isoforms. Strikingly, these differences are 
apparent in two different contexts. On one hand, at higher temperatures longevity of IIS 
mutants is further increased by the daf-12(m20) mutation while the daf-12(rh61rh411) null 
allele does not change their lifespan (Tab. 1) (Gems et al., 1998, Larsen et al., 1995, 
McCulloch and Gems, 2007, Dumas et al., 2013). On the other hand, the different daf-12 
mutations have different effects on germline longevity (Tab. 1). The original experiments 
showing that germline longevity is dependent on daf-12, with deletion of the somatic gonad 
having no effect, were done with the daf-12(m20) allele, which leaves the DAF-12B isoform 
unaffected (Hsin and Kenyon, 1999, Antebi et al., 2000). However, in daf-12(rh61rh411) null 
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mutants, ablation of germline stem cells and somatic gonad increases lifespan slightly 
(Yamawaki et al., 2010). These findings imply that different DAF-12 isoforms exhibit 
important differences in their impact on longevity. DAF-12B lacks the DBD, but the functional 
relevance of this isoform is unknown. It is thought to sequester DAs without affecting 
transcription of DAF-12 targets and/or to heterodimerize with other NHRs and to modulate 
their transactivating activity (Fig. 3) (Antebi et al., 2000, Gissendanner et al., 2004). If DAF-
12B acts solely as a ligand scavenger, this finding would imply that DAs have targets other 
than DAF-12. Since the fully functional DAF-12 protein is not present in the daf-12(m20) 
mutants, scavenging of DAs can only be effective if there is another receptor that can 
respond to their absence or presence. If DAF-12B acts as a heterodimerization partner for 
other NHRs, then their interaction has considerable relevance for the modulation of healthy 
aging. In either case the functional differences of DAF-12 isoforms and their impact on 
healthy aging could provide detailed molecular evidence on the possible roles of both 
xenobiotic and lipid metabolism in healthy aging from DAF-12.  
Another important step to understand the role of NR1J group members in healthy aging will 
be to identify their cognate ligands and the enzymes involved in their biosynthesis and 
degradation. NHR-8 is an orphan, however, given its modular structure and its close 
homology to DAF-12, it is highly probable that it has a ligand. Extrapolation from the DAF-12 
ligands is unlikely to be informative because worm NHRs show low sequence identity within 
the LBD (< 30 %) (Gissendanner et al., 2004). In an attempt to identify NHR-8 ligands, the 
xenobiotics chloroquine and colchicine, as well as several sterol derivatives known to be 
bound by mammalian LXR, were tested in a ligand-sensor screen, but they did not 
transactivate NHR-8 (Magner et al., 2013). Several attempts have been made to identify 
DHR96 ligands. A promising candidate is cholesterol or a closely related derivative, because 
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cholesterol co-purifies with the DHR96 LBD (Horner et al., 2009) However, neither 
supplementation of cholesterol nor reduction of cholesterol availability by different means 
changed DHR96 activity (Horner et al., 2009). To identify and/or confirm the ligands of NHR-8 
and DHR96 it will be preferable to use in vivo rather than in vitro assays, because their 
transactivating activity is dependent on heterodimerization partners and co-regulators which 
may not be present in cell culture systems.  
Apart from the known interaction of DAF-12 with the co-repressor DIN-1, it is unclear which 
dimerization partners and/or co-regulators are required for DAF-12, NHR-8 and DHR96 to 
exert their functions, and whether availability of these proteins differs at different life history 
stages and in different tissues. DAF-12 contains a homodimerization domain in its LBD 
(Antebi et al., 2000) and its response elements commonly contain inverted or direct repeats, 
indicating that it binds to the DNA as a dimer (Shostak et al., 2004). However, formation of 
homo- or heterodimers by DAF-12 has not yet been reported. One interesting candidate for a 
DHR96 dimerization partner is Ultraspiracle (USP), the ortholog of RXR in flies. USP forms the 
receptor for 20E together with ecdysone receptor (EcR), which has been implicated in 
modulating healthy aging (Yao et al., 1993, Horner et al., 1995, Maletta et al., 2014, Simon et 
al., 2003, Tricoire et al., 2009). Interestingly, DHR96 binds the hsp27 ecdysone response 
element, suggesting a possible heterodimerization between DHR96 and USP (Fisk and 
Thummel, 1995). Notably, in mammals RXR is the only heterodimerization partner for all 
other NHRs and USP may have a similar function in flies. However, it is also possible that 
DHR96 competes with EcR/USP for binding sites and shares target genes with the 20E 
receptor. Given that DHR96 also regulates catabolism of 20E by regulating expression of 
CYP18a1 (King-Jones et al., 2006, Guittard et al., 2011), EcR and DHR96 signaling might cross-
talk in modulating healthy aging, possibly by sharing the heterodimerization partner USP. 
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Studying the interaction of DHR96 and USP could thus be revealing of molecular 
mechanisms.  
 
Conclusion and outlook 
Increased xenobiotic resistance is a commonly observed phenotype in many long-lived 
worms, flies and rodents. Members of the NR1J group are important modulators of health 
during aging. These NHRs and their close mammalian homologs control xenobiotic 
detoxification but also sterol and triglyceride metabolism. Evidence is not yet sufficient to 
assess xenobiotic resistance as a cause for healthy aging, because most of the data are 
correlative in nature, and they are also largely confined to C. elegans and Drosophila. 
Furthermore, due to the overlapping functions of xenobiotic detoxification genes with sterol 
metabolism, xenobiotic resistance is tightly linked with the biosynthesis and degradation of 
steroid hormones and bile acids. It is therefore possible that the increased expression of 
xenobiotic detoxification genes in long-lived models reflects changes in levels of bile acids or 
steroid hormones. In invertebrates, steroid hormones modulate health during aging and in 
mice bile acids elicit expression profiles of detoxification genes similar to the ones found in 
long-lived mice. Finally, it is likely that NHRs of the NR1J group contribute to health during 
aging by controlling lipid metabolism because they regulate lipid-modifying enzymes that are 
necessary and/or sufficient to extend lifespan in C. elegans. NHRs of the NR1J group and 
their mammalian homologs may therefore contribute to health during aging by balancing 
sterol and lipid metabolism and xenobiotic resistance (Fig. 4). On one hand, by regulating 
enzymes of phase I, II and, III of endo-and xenobiotic detoxification NHRs can decrease the 
load of toxic endo- and xenobiotic molecules and promote somatic maintenance. On the 
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other hand, they provide for homoeostasis of steroid hormones, bile acids and other sterol 
metabolites and can maintain a healthy lipid profile.  
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Table 1: DA/DAF-12 signaling affects longevity in a context dependent manner. 
DA/DAF-12 
signaling 
mutant/ 
intervention 
temp.  
(C°) 
genetic background/intervention 
Reference 
wt  
daf-2 (class 1) 
daf-2 
(class 2) 
daf-
2 
RNAi 
daf-
16 
germ 
cell 
ablat. 
e1368 m41 e1370  
daf-9 (e1406) 15 + 
     
 Jia et al., 2002 
daf-9 (e1406) 15 + 
     
 Gerisch et al., 2001 
daf-9 (dh8) 15 + 
     
 Gerisch et al., 2001 
daf-9 (dh6) 15 + 
     
 Gerisch et al., 2007 
daf-9 (e1406) 15 + 
     
 Gerisch et al., 2007 
daf-9(rh50) 15 
 
- 
 
- 
  
 Gerisch et al., 2001 
daf-9 (e1406) 15 
     
=  Jia et al., 2002 
daf-9(rh50) 15 
     
=  Gerisch et al., 2001 
daf-9 (e1406) 20 = 
     
 Jia et al., 2002 
daf-9(rh50) 20 
    
- 
 
 Thondamal et al., 2014 
daf-9(rh50) 22.5 - - 
 
+ 
  
 Gerisch et al., 2001 
daf-9 (e1406) 25 = 
     
 Jia et al., 2002 
daf-9 (k182) 25 - - 
    
 Dumas et al., 2013 
daf-9 (k182) 25 
    
-- 
 
 Dumas et al., 2013 
daf-9(rh50) + 
∆7-DA 
20 = 
     
 Thondamal et al., 2014 
∆4-DA 22.5 
 
+ 
 
= 
  
 Gerisch et al., 2007 
daf-12 (m20)* 15 
  
- = 
  
 Gems et al., 1998 
daf-12 
(rh61rh411)** 
20 
   
-/= 
  
 Dumas et al., 2013 
daf-12 
(rh61rh411)** 
20 - 
     
 Fisher and Lithgow, 2006 
daf-12 
(rh273)*** 
20 + 
     
 Fisher and Lithgow, 2006 
daf-12 (m20)* 22.5 
  
-/= =/+ 
  
 Gems et al., 1998 
daf-12 (m20)* 22.5 -/= 
 
- + 
  
 McCulloch et al., 2007 
daf-12 
(rh61rh411)** 
25 = = 
 
= 
  
 Dumas et al., 2013 
daf-12 
(rh61rh411)** 
25 
    
-- 
 
 Dumas et al., 2013 
daf-12 (m20)* 25.5 
   
+ 
  
 Larsen et al., 1995 
daf-9(rh50) 20       -- Gerisch et al., 2001 
daf-9 (dh6) 20       -- Gerisch et al., 2001 
daf-12 (m20)* 20       -- Hsin and Kenyon, 1999 
daf-12 
(rh61rh411)** 
20       = Yamawaki et al., 2010 
*non null, only DAF-12A is affected, DAF-12B is transcribed normally; ** null; *** LBD deficient; + DA/DAF-12 
mutant/intervention increased longevity compared to background; =  no change compared to background; 
- DA/DAF-12 mutant/intervention decreased longevity compared to background 
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Fig. 1. Phylogenetic relationships between NHRs implicated in xenobiotic metabolism in worms, flies and 
mammals. The large superfamily of NHRs is classified into 6 classes of which only NR1 is depicted here. NHRs 
involved in xenobiotic metabolism in invertebrates belong to subgroup NR1J and include DHR96, NHR-8, DAF-12 
and NHR-48. Subgroup NR1J is closely related to subgroup NR1I, which harbors the mammalian xenobiotic 
receptors PXR, CAR and VDR. In close proximity, mammalian bile acid and cholesterol sensors, FXR and LXRs, 
respectively, are located in subgroup NR1H. Distances between nodes are not to scale and branches of other 
subgroups have been merged for simplicity. Adapted from (Maglich et al., 2001) and (Bertrand et al., 2004).  
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Fig. 2. Structure and molecular functions of NHRs. A) The N-terminal A/B domain is variable and serves in 
ligand-independent transactivation. The central C domain is highly conserved and harbors two zinc finger motifs 
through which the NHR binds to the DNA. The highly variable hinge region or D domain connects DBD and LBD 
and also facilitates DNA binding through the C terminal extensions. The E domain comprises the LBD, which 
serves in ligand-dependent transactivation. The LBD furthermore contains motifs necessary for dimerization 
and association of co-regulators, which are modulated by ligand binding. B) NHRs can bind the DNA as 
monomers, homo- or heterodimers. This is reflected in the arrangement of the hexameric half sites of their 
binding motif. Monomers bind to single half sites, while homodimers and heterodimers bind to inverted and 
direct repeats, respectively. C) Modes of transcriptional regulation through NHRs and their ligands. Top: 
Classicly, in the absence of the ligand, NHRs are associated with co-repressors and silence target gene 
expression. Upon binding of a lipophilic ligand, NHRs form homo- or heterodimers and associate with co-
activators, resulting in expression of target genes. Middle: Some NHRs are constitutively active and ligand 
binding induces repression of transcription (inverse agonism). Bottom: Independent of ligand-binding, NHRs can 
constitutively repress (bottom left), or constitutively activate (bottom right) transcription. 
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Fig. 3. Different molecular functions of  DAF-12 isoforms. DAF-12 A isoforms comprise both LBD and DBD while 
DAF-12B lacks the DBD. In the absence of DAs, DAF-12A is bound to the co-repressor DIN-1 and represses 
transcription of target genes while transcription is activated when DA is bound. DAF-12B might either sequester 
DAs and thereby repress transcription from DAF-12A (A) or heterodimerize with another unknown NHR and 
regulate its transactivating activity dependent or independent of DA availability (B). 
 
 
40 
 
 
 
 
Fig. 4. Model how NHRs could balance sterol and xenobiotic metabolism to modulate healthy aging. NHR-8, 
DAF-12, DHR96, and FXR regulate enzymes involved in phase I, II, and III of endo- and xenobiotic detoxification. 
Due to their broad substrate specificities these enzymes are also involved in biosynthesis and degradation of 
sterol metabolites like steroid hormones or bile acids whose homeostasis is critical for healthy aging, possibly 
by maintaining healthy lipid profiles. Different interventions that extend lifespan in C. elegans, Drosophila and 
rodents either act through the NHRs depicted and/or increase expression of xenobiotic detoxification genes and 
xenobiotic  resistance (for details see text). Noteably, these interventions also act through other downstream 
mediators to modulate healthy aging which are not depicted here for clarity. CYPs, cytochrome P 450 enzymes; 
DR, dietary restriction; GSTs, glutathione-S-transferases; IIS, insulin/insulin-like growth factor signaling; SDRs, 
short chain dehydrogenases; STs, sulfotransferases; UGTs, UDP-glucuronosyltransferases. 
 
 
